EPGN-1370

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEPGN-1370
Drug Alias NameEPGN-1370
ClassificationSmall molecules
Mechanisms of Action70-kDa ribosomal protein S6 kinases inhibitors
Targets70-kDa ribosomal protein S6 kinases
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpigen Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpigen Biosciences Inc
Inactive CompaniesN/A
Active IndicationsFragile X Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A